Skip to main content

Table 1 Clinical and metabolic parameters of the subjects

From: Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women

Parameters

Normal weight

(N = 22)

Overweight

(N = 34)

Obese

(N = 34)

Age (years)

38.38 ± 11.54

44.71 ± 6.15

44.13 ± 8.42*

BMI (kg/m2)

22.54 ± 2.34

27.73 ± 2.21*

35.76 ± 3.48

Systolic BP (mmHg)

119.86 ± 14.26

127.53 ± 29.81

130.63 ± 15.78*

Diastolic BP (mmHg)

78.76 ± 9.15

76.82 ± 10.58

82.67 ± 12.77

Waist (cm)

90.0 ± 8.98

91.45 ± 8.52

107.57 ± 10.21*

Hips (cm)

92.86 ± 7.31

97.48 ± 8.23

107.0 ± 14.24*

Glucose (mmol/L)

7.28 ± 3.4

8.49 ± 3.86

8.13 ± 4.1

Insulin (μIU/ml)#

15.19 (1.83–42.75)

16.2 (0.51–42.25)

18.82 (2.45–55.82)

HOMA-IR #

5.46 (0.33–22.23)

5.91 (0.17–14.68)

7.0 (0.19–43.66)

Total cholesterol (mmol/L)

4.93 ± 0.92

4.84 ± 1.07

4.7 ± 1.3

LDL-cholesterol (mmol/L)

2.96 ± 0.75

2.77 ± 0.71

2.81 ± 1.01

HDL-cholesterol (mmol/L)

1.26 ± 0.34

1.22 ± 0.37

1.22 ± 0.32

Triglycerides (mmol/L)#

1.33 (0.5–3.04)

1.79 (0.43–7.41)

2.01 (0.43–20.49)

Leptin (ng/ml)#

16.4 (3.2–45.90)

24.86 (1.27–77.60)

35.28 (4.04–120)*

Adiponectin (μg/ml)#

7.6 (2.39–16.90)

4.6 (1.72–9.39)*

4.7 (1.9–7.95) *

CRP (μg/ml)#

2.3 (0–13.30)

5.2 (0–205.0)

6.9 (0.07–34.20)*

TNF-α (pg/ml)

4.8 ± 1.88

4.7 ± 2.0

4.5 ± 1.6

IL-6 (pg/ml)#

4.6 (0.07–10.34)

4.9 (0.11–24.1)

8.3 (0.28–45.30)*

TGF-α (pg/ml)#

13.8 (7.9–42.34)

11.6 (7.0–28.58)

12.3 (7.9–23.01)

  1. Data presented as mean ± SD; parameters marked # indicate median (range); * denotes significance compared to normal weight group; ¶denotes significance compared to normal and over weight groups. ¶*P < 0.05